- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT03521752
Influence of an Exercise Program in the Elderly Balance
Influence of a Specific Exercise Program in the Institutionalized Elderly Balance
This study has the objective to determinate the effectiveness of a specific exercise program on balance and functional capacity of the daily activities of institutionalized elderly.
It was a randomized controlled trial with a total of 21 elderly that were randomly distributed into experimental (n = 11) and control groups (n=10). The experimental group performed a specific program exercises during 4 weeks, while the control group wasn't subjected to any intervention. Evaluations were carried out at the beginning and end of the exercise program, for both groups. After the intervention there were no statistically significant differences between groups in total balance and dynamic balance subscale, except static balance subscale.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Age ≥ 65 years
- institutionalized elderly
- Both genders
- Mini-Mental ≥19 pontos
- Protocol attendance ≥ 90%
Exclusion Criteria:
- Cardiovascular diseases
- Contraindication to physical exercise
- Medication (anxiolytics, antidepressants)
- Vestibular disorders
- Previous physiotherapy of 6 months to the present study
- Neurological and neuromuscular diseases
- Use of gaiters
- Another type of physical exercise during the study
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Annen
- Tildeling: Randomisert
- Intervensjonsmodell: Crossover-oppdrag
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Experimental
Performed a specific program exercises (resistance training, balance, coordination and flexibility) during 4 weeks.
|
4 weeks of exercise classes, 2 to 3 times a week for a total of 10 sessions.
Classes last approximately 40 minutes.
The sessions included balance training, motor strength, endurance and flexibility.
The training sessions were divided into warm-up, main activity and finally relaxation.
|
|
Ingen inngripen: Control
The control group wasn't subjected to any intervention
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Balance
Tidsramme: 4 weeks
|
Performance Oriented Mobility Assessment (POMA) This scale measures the static and dynamic balance, through the evaluation of some daily activities. This scale's scores are between 9 to 28 points, when 9 means hig risk of falling, and 28 means low risk of falling. It was used before and after the intervention. |
4 weeks
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Functional capacity
Tidsramme: 4 weeks
|
Timed up and Go (TUG) This scale measures the mobility and locomotor performance, through the timing of an activity (lift from a chair, walk 3 meters, change direction and return to starting position). The cut-off points of the scale are divided into fully independent elderly (<10 seconds), independent elderly (10-19 seconds), and elderly people with difficulties in the tasks of daily living (20-29 seconds). It was evaluated before and after the intervention. |
4 weeks
|
Samarbeidspartnere og etterforskere
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Andre studie-ID-numre
- 1CESPU
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .